- eFFECTOR Therapeutics Inc R&D Day TranscriptJan 24, 2024
- eFFECTOR Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 26, 2023
- eFFECTOR Therapeutics Inc at JMP Securities Life Sciences Conference TranscriptMay 15, 2023
- eFFECTOR Therapeutics Inc Provides Positive Clinical Data Update for Zotatifin and General Corporate Update Call TranscriptJan 05, 2023
- eFFECTOR Therapeutics Inc at Stifel Healthcare Conference TranscriptNov 15, 2022
- eFFECTOR Therapeutics Inc at Credit Suisse Healthcare Conference TranscriptNov 08, 2022
- eFFECTOR Therapeutics Inc at JMP Securities Life Sciences Conference TranscriptJun 15, 2022
- eFFECTOR Therapeutics Inc Update on Expanded Development of Zotatifin - Corporate Call TranscriptJun 05, 2022
- eFFECTOR Therapeutics Inc Provides Pipeline and Business Updates - Conference Call TranscriptJan 24, 2022
eFFECTOR Therapeutics Inc at Credit Suisse Healthcare Conference Transcript
Good afternoon, everyone. I'm Judah Frommer. I'm one of the SMID-cap biotech analysts here at Credit Suisse. And for this session, we're very happy to have the team from eFFECTOR here: Steve, Mike, and Doug.
So maybe if we just jump right in. We thought we could start with a background question on the platform and the origin story for -- how did you land on the eIF4F translation complex? And how should we think about the optionality available for potential therapeutic mechanisms?
Questions & Answers
Yeah. Thanks, Judah. Thanks for the invitation. It's great to be here. I mean, I'll start with that. And then -- a lot of other people join in.
So I think the idea with the translational complex was, one, recognizing where it sits in cell signaling. So it's downstream of the RAS and the PI3K pathways, and it's actually a point of convergence of those two pathways, one of the very early points in signaling where the two pathways
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)